[1]
|
NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
STRAIN=C3H/He, and C57BL/6;
TISSUE=Kidney;
PubMed=1374387 [NCBI, ExPASy, EBI, Israel, Japan]
Jiang W.,
Gorbea C.M.,
Flannery A.V.,
Beynon R.J.,
Grant G.A.,
Bond J.S.;
"The alpha subunit of meprin A. Molecular cloning and sequencing, differential expression in inbred mouse strains, and evidence for divergent evolution of the alpha and beta subunits.";
J. Biol. Chem. 267:9185-9193(1992).
|
[2]
|
PROTEIN SEQUENCE OF 21-25 AND 65-69.
PubMed=8615815 [NCBI, ExPASy, EBI, Israel, Japan]
Beynon R.J.,
Oliver S.,
Robertson D.H.L.;
"Characterization of the soluble, secreted form of urinary meprin.";
Biochem. J. 315:461-465(1996).
|
[3]
|
NUCLEOTIDE SEQUENCE OF 64-262.
PubMed=1939172 [NCBI, ExPASy, EBI, Israel, Japan]
Dumermuth E.,
Sterchi E.E.,
Jiang W.,
Wolz R.L.,
Bond J.S.,
Flannery A.V.,
Beynon R.J.;
"The astacin family of metalloendopeptidases.";
J. Biol. Chem. 266:21381-21385(1991).
|
[4]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 62-258.
STRAIN=129;
DOI=10.1016/S0378-1119(96)00834-7; PubMed=9161413 [NCBI, ExPASy, EBI, Israel, Japan]
Jiang W.,
Flannery A.V.;
"Correlation of the exon/intron organization to the secondary structures of the protease domain of mouse meprin alpha subunit.";
Gene 189:65-71(1997).
|
[5]
|
CHARACTERIZATION.
DOI=10.1021/bi00098a029; PubMed=1883833 [NCBI, ExPASy, EBI, Israel, Japan]
Wolz R.L.,
Harris R.B.,
Bond J.S.;
"Mapping the active site of meprin-A with peptide substrates and inhibitors.";
Biochemistry 30:8488-8493(1991).
|
[6]
|
3D-STRUCTURE MODELING.
PubMed=8508794 [NCBI, ExPASy, EBI, Israel, Japan]
Stoecker W.,
Gomis-Rueth F.-X.,
Bode W.,
Zwilling R.;
"Implications of the three-dimensional structure of astacin for the structure and function of the astacin family of zinc-endopeptidases.";
Eur. J. Biochem. 214:215-231(1993).
|
|
ExPASy Home page
APAF Australia
